A number of other analysts have also recently weighed in on the company. BidaskClub raised INC Research from a hold rating to a buy rating in a research report on Wednesday, January 3rd. TheStreet cut INC Research from a b- rating to a c rating in a research report on Monday, December 18th. Barclays assumed coverage on INC Research in a research report on Monday, December 11th. They issued an equal weight rating and a $40.00 price target for the company. SunTrust Banks reduced their price target on INC Research to $50.00 and set a buy rating for the company in a research report on Friday, December 1st. Finally, Mizuho set a $41.00 price target on INC Research and gave the stock a neutral rating in a research report on Friday, December 1st. One research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company. INC Research presently has an average rating of Buy and a consensus price target of $50.78.
INC Research (NASDAQ SYNH) traded up $0.10 on Thursday, reaching $42.20. The company had a trading volume of 590,400 shares, compared to its average volume of 1,149,975. INC Research has a 52-week low of $33.60 and a 52-week high of $61.10. The firm has a market capitalization of $8,810.00, a PE ratio of -74.04, a price-to-earnings-growth ratio of 1.25 and a beta of 1.09. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.99.
INC Research (NASDAQ:SYNH) last announced its quarterly earnings results on Thursday, November 9th. The company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.63 by ($0.09). INC Research had a negative return on equity of 35.13% and a negative net margin of 18.00%. The company had revenue of $592.21 million during the quarter, compared to analyst estimates of $604.95 million. During the same period in the prior year, the firm earned $0.64 EPS. INC Research’s quarterly revenue was up 128.2% on a year-over-year basis. research analysts forecast that INC Research will post 2.15 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://ledgergazette.com/2018/01/12/inc-research-incr-given-buy-rating-at-keycorp.html.
INC Research Company Profile
Syneos Health, Inc, formerly INC Research Holdings, Inc, is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with MarketBeat.com's FREE daily email newsletter.